Your browser doesn't support javascript.
loading
Prognostic Significance of BIRC5/Survivin in Breast Cancer: Results from Three Independent Cohorts.
Oparina, Nina; Erlandsson, Malin C; Fäldt Beding, Anna; Parris, Toshima; Helou, Khalil; Karlsson, Per; Einbeigi, Zakaria; Bokarewa, Maria I.
  • Oparina N; Department of Rheumatology and Inflammation Research, Institute of Medicine, University of Gothenburg; 40530 Gothenburg, Sweden.
  • Erlandsson MC; Department of Rheumatology and Inflammation Research, Institute of Medicine, University of Gothenburg; 40530 Gothenburg, Sweden.
  • Fäldt Beding A; Rheumatology Clinic, Sahlgrenska University Hospital, 41345 Gothenburg, Sweden.
  • Parris T; Department of Medicine and Oncology, Southern Älvsborg Hospital, 50182 Borås, Sweden.
  • Helou K; Department of Oncology, Institute of Clinical Science at Sahlgrenska Academy, University of Gothenburg, 40530 Gothenburg, Sweden.
  • Karlsson P; Department of Oncology, Institute of Clinical Science at Sahlgrenska Academy, University of Gothenburg, 40530 Gothenburg, Sweden.
  • Einbeigi Z; The King Gustav Vth Jubilee Clinic, Sahlgrenska University Hospital, 41345 Gothenburg, Sweden.
  • Bokarewa MI; Department of Oncology, Institute of Clinical Science at Sahlgrenska Academy, University of Gothenburg, 40530 Gothenburg, Sweden.
Cancers (Basel) ; 13(9)2021 May 04.
Article en En | MEDLINE | ID: mdl-34064473
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Año: 2021 Tipo del documento: Article